Tao Su Selected Research

STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)

1/2023	Brevilin A is a potent anti-metastatic CRC agent that targets the VEGF-IL6-STAT3 axis in the HSCs-CRC interplay.
1/2020	The JAK2/STAT3 pathway is involved in the anti-melanoma effects of brevilin A.
1/2017	Inhibiting STAT3 signaling is involved in the anti-melanoma effects of a herbal formula comprising Sophorae Flos and Lonicerae Japonicae Flos.
2/2016	Inhibition of the STAT3 signaling pathway contributes to apigenin-mediated anti-metastatic effect in melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tao Su Research Topics

Disease

59	Neoplasms (Cancer) 03/2024 - 03/2002
17	Breast Neoplasms (Breast Cancer) 02/2024 - 04/2005
14	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 11/2011
13	Neoplasm Metastasis (Metastasis) 02/2024 - 04/2005
12	Interstitial Nephritis (Tubulointerstitial Nephritis) 03/2024 - 04/2010
12	Melanoma (Melanoma, Malignant) 01/2020 - 02/2014
11	Infections 03/2024 - 03/2006
11	Stomach Neoplasms (Stomach Cancer) 11/2023 - 02/2010
11	Inflammation (Inflammations) 01/2023 - 03/2006
11	Carcinogenesis 02/2022 - 06/2003
10	Epilepsy (Aura) 01/2023 - 07/2006
10	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 12/2011
9	Acute Kidney Injury (Acute Renal Failure) 12/2024 - 01/2012
7	Fibrosis (Cirrhosis) 01/2024 - 02/2014
7	Seizures (Absence Seizure) 01/2023 - 01/2005
5	Obesity 02/2024 - 01/2017
5	Pain (Aches) 12/2023 - 06/2008
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 03/2020
5	Lung Neoplasms (Lung Cancer) 02/2022 - 02/2014
5	IGA Glomerulonephritis (IGA Nephropathy) 01/2022 - 09/2008
5	Acute Tubulointerstitial Nephritis 01/2022 - 04/2010
5	Cognitive Dysfunction 01/2018 - 01/2014
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2024 - 03/2006
4	Liver Neoplasms (Liver Cancer) 11/2023 - 06/2009
4	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 07/2013
4	Carcinoma (Carcinomatosis) 01/2022 - 11/2011
4	Edema (Dropsy) 01/2022 - 07/2010
4	Glomerulonephritis 01/2022 - 07/2014
4	Hypoxia (Hypoxemia) 01/2022 - 07/2014
4	Body Weight (Weight, Body) 01/2022 - 02/2016
4	Myocardial Infarction 09/2017 - 02/2014
3	Arthritis (Polyarthritis) 12/2023 - 07/2013
3	Hepatocellular Carcinoma (Hepatoma) 09/2023 - 07/2019
3	Lymphatic Metastasis 08/2023 - 04/2005
3	Renal Insufficiency (Renal Failure) 05/2023 - 01/2012
3	Thrombocytopenia (Thrombopenia) 01/2023 - 10/2020
3	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 09/2008
3	Partial Epilepsies (Epilepsy, Partial) 01/2023 - 09/2010
3	Hemorrhage 01/2023 - 06/2017
3	Nasopharyngeal Carcinoma 01/2022 - 08/2010
3	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2012
3	Wounds and Injuries (Trauma) 01/2022 - 01/2019
3	Testicular Neoplasms (Testicular Cancer) 03/2021 - 01/2012
3	Tubulointerstitial nephritis and uveitis 11/2020 - 01/2011
3	Necrosis 10/2020 - 05/2014
3	Hyponatremia 03/2018 - 09/2014

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 02/2024 - 06/2003
18	Biomarkers (Surrogate Marker)IBA 01/2024 - 03/2006
10	Formaldehyde (Formol)FDA Link 01/2018 - 10/2012
9	RNA (Ribonucleic Acid)IBA 01/2023 - 03/2007
8	Messenger RNA (mRNA)IBA 12/2023 - 09/2007
7	CreatinineIBA 12/2024 - 01/2012
7	LipidsIBA 10/2022 - 06/2009
7	AntigensIBA 01/2022 - 01/2011
6	EnzymesIBA 05/2023 - 01/2014
6	MicroRNAs (MicroRNA)IBA 01/2023 - 02/2010
6	LigandsIBA 01/2023 - 01/2012
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2023 - 12/2014
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 09/2008
5	Interleukin-6 (Interleukin 6)IBA 01/2023 - 07/2010
5	Therapeutic UsesIBA 01/2023 - 07/2014
5	Peptides (Polypeptides)IBA 12/2022 - 02/2016
5	Glucose (Dextrose)FDA LinkGeneric 08/2022 - 10/2015
5	Palmitic Acid (Hexadecanoic Acid)IBA 12/2021 - 10/2014
5	Immunoglobulin G (IgG)IBA 01/2019 - 01/2011
4	TinIBA 03/2024 - 01/2021
4	Glycoproteins (Glycoprotein)IBA 12/2023 - 01/2020
4	aristolochic acid I (aristolochic acid)IBA 11/2023 - 09/2005
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 12/2014
4	Complement System Proteins (Complement)IBA 01/2023 - 01/2016
4	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2023 - 02/2016
4	DNA (Deoxyribonucleic Acid)IBA 09/2022 - 03/2002
4	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 10/2014
4	AntibodiesIBA 01/2022 - 01/2017
4	VaccinesIBA 03/2021 - 01/2012
4	Ribose (D-Ribose)IBA 11/2017 - 03/2014
4	Phosphotransferases (Kinase)IBA 01/2016 - 08/2009
3	CateninsIBA 11/2023 - 05/2017
3	brevilin AIBA 08/2023 - 01/2020
3	ApigeninIBA 07/2023 - 02/2016
3	Hormones (Hormone)IBA 05/2023 - 04/2005
3	C-Reactive ProteinIBA 01/2023 - 01/2011
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 11/2010
3	GlycopeptidesIBA 01/2022 - 01/2020
3	Protein Isoforms (Isoforms)IBA 01/2022 - 01/2016
3	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022 - 09/2009
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022 - 09/2010
3	Complementary DNA (cDNA)IBA 03/2021 - 12/2010
3	MethyltransferasesIBA 01/2021 - 01/2015
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 12/2009
3	Amyloid (Amyloid Fibrils)IBA 05/2020 - 10/2012
3	BerberineIBA 08/2017 - 12/2011
3	MelatoninIBA 03/2016 - 12/2011
3	Serum AlbuminIBA 02/2016 - 07/2014

Therapy/Procedure

37	Therapeutics 01/2023 - 03/2007
6	Drug Therapy (Chemotherapy) 11/2023 - 11/2010
4	Transplantation 01/2023 - 09/2008
3	Renal Replacement Therapy (Therapies, Renal Replacement) 05/2023 - 06/2017
3	Intraperitoneal Injections 01/2020 - 11/2014
3	Oral Administration 01/2017 - 10/2015